COMMUNIQUÉS West-GlobeNewswire

Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
06/06/2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 6 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
06/06/2025
FLORHAM PARK, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT) today announced that the U.S. Food and Drug Administration (FDA) has approved Phathom’s Citizen Petition filed on [...]
SPINEWAY : Compte-rendu de l’Assemblée Générale du 4 juin 2025
06/06/2025
Communiqué de presse Ecully, le 6 juin 2025 – 18h SPINEWAY Compte-rendu de l’Assemblée Générale du 4 juin 2025 L'Assemblée Générale Mixte (Ordinaire et Extraordinaire) des actionnaires de Spineway s'est tenue sur [...]
Spineway : Minutes of the General Meeting of June 4, 2025
06/06/2025
Press release Ecully, June 6, 2025 – 6.00 p.m. SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on first notice on [...]
Fagron increases share capital through exercise subscription rights
06/06/2025
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 – 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of the exercise of [...]
Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC
06/06/2025
Moderated webcast fireside chat with members of Senti management and Chardan senior research analyst, Geulah Livshits, PhD on Monday, June 9th at 3:00 PM ET SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE [...]
Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
06/06/2025
Robust proteinuria reduction and stable kidney function were maintained across a broad population of patients No new safety signals were observed New data presented at late-breaking session at the European Renal [...]
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
06/06/2025
Mr. Chin brings over 20 years of financial experience across public and private healthcare organizations Mr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent [...]
Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials
06/06/2025
PRINCETON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat [...]
Immix Biopharma Attends FDA CEO Forum in Washington DC
06/06/2025
– Selected to Attend In-Person Event on June 5 led by FDA Commissioner Marty A. Makary, M.D., M.P.H. – LOS ANGELES, CA, June 06, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ” [...]
President of the Association of American Physicians and Surgeons (AAPS) Writes, ‘Let’s Make America Healthy Again’
06/06/2025
TUCSON, Ariz., June 06, 2025 (GLOBE NEWSWIRE) -- The Make America Healthy Again (MAHA) project is a monumental task, writes Erika L. LeBaron, DO., M.S.N., in the summer issue of the Journal of American Physicians and [...]
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
06/06/2025
TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( "Spectral" or the "Company" ) (TSX: EDT) , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced [...]
Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model
06/06/2025
Data featured in oral presentation and poster session at 48 th European Cystic Fibrosis Conference WALTHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage [...]
BioNTX to Join Strategic Partners at BIO International Convention, Showcasing North Texas as a Converging Life Sciences Powerhouse
06/06/2025
DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- BioNTX , the leading voice of the bioscience and healthcare innovation ecosystem in North Texas, is proud to announce its attendance at the upcoming 2025 BIO International [...]
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
06/06/2025
Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an orally administered treatment for DMD in patients 6 years and older [...]
Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
06/06/2025
$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Venus Concept [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
06/06/2025
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 06 juin 2025 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
Press release: Transparency Notification from Shareholders
06/06/2025
Transparency Notification from Shareholders Ghent, Belgium – 6 June 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]
Polpharma Group soutient l’action urgente de l’UE visant à garantir l’accès aux médicaments et à renforcer la souveraineté pharmaceutique européenne
06/06/2025
En tant que membre de l’association Medicines for Europe, Polpharma Group se joint aux leaders du secteur pour appeler les Premiers ministres de l’UE à adopter un plan d’action pharmaceutique en cinq points destiné à [...]

Pages